A detailed history of Bryn Mawr Trust CO transactions in Organon & Co. stock. As of the latest transaction made, Bryn Mawr Trust CO holds 9,662 shares of OGN stock, worth $142,321. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,662
Holding current value
$142,321
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024

BUY
$18.65 - $23.03 $180,196 - $222,515
9,662 New
9,662 $184,000
Q1 2022

May 16, 2022

SELL
$30.45 - $39.36 $497,583 - $643,181
-16,341 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$28.67 - $37.13 $34,432 - $44,593
-1,201 Reduced 6.85%
16,341 $497,000
Q3 2021

Oct 26, 2021

SELL
$28.63 - $35.64 $55,198 - $68,713
-1,928 Reduced 9.9%
17,542 $574,000
Q2 2021

Jul 29, 2021

BUY
$28.45 - $38.0 $553,921 - $739,860
19,470 New
19,470 $589,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.